Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma
NCT05070728: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Terminated
3
12
US
Sham Injector, Sham Comparator, FAI Insert, Active Drug
EyePoint Pharmaceuticals, Inc.
Uveitis, Uveitis, Posterior, Uveitis, Intermediate
10/22
04/23
TYNI, NCT05486468: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Recruiting
3
30
US
Yutiq 0.18 MG Drug Implant, Sham Injection
Texas Retina Associates, Eye Point Pharmaceuticals
Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate
12/23
12/24

Download Options